Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Nov 14, 2024

BUY
$191.17 - $325.63 $6.83 Million - $11.6 Million
35,716 Added 24.95%
178,880 $58.2 Million
Q1 2024

May 13, 2024

BUY
$191.17 - $325.63 $34.2 Million - $58.2 Million
178,880 New
178,880 $58.2 Million
Q4 2023

Nov 14, 2024

BUY
$160.99 - $215.69 $23 Million - $30.9 Million
143,164 New
143,164 $27.3 Million
Q4 2023

Feb 09, 2024

BUY
$160.99 - $215.69 $10.8 Million - $14.5 Million
67,236 Added 88.55%
143,164 $27.3 Million
Q3 2023

Nov 14, 2023

SELL
$194.33 - $283.97 $1.75 Million - $2.56 Million
-9,006 Reduced 10.6%
75,928 $15.1 Million
Q2 2023

Aug 11, 2023

BUY
$223.05 - $302.68 $6.72 Million - $9.12 Million
30,131 Added 54.98%
84,934 $24.2 Million
Q1 2023

May 12, 2023

BUY
$175.41 - $217.92 $7.43 Million - $9.23 Million
42,334 Added 339.51%
54,803 $11.9 Million
Q4 2022

Feb 13, 2023

BUY
$204.38 - $296.82 $2.55 Million - $3.7 Million
12,469 New
12,469 $2.56 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.